Mong‐Lien Wang
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 10
- Retinal Development and Disorders 9
- RNA modifications and cancer 9
-
- MicroRNA in disease regulation 14
- Cancer-related molecular mechanisms research 13
- Co-authors
- Shih‐Hwa Chiou (38 shared papers)Chian‐Shiu Chien (25 shared papers)Aliaksandr A. Yarmishyn (25 shared papers)Shih-Hwa Chiou (4 shared papers)Yueh Chien (26 shared papers)Yi‐Ping Yang (17 shared papers)Yung‐Hung Luo (8 shared papers)Shih‐Jie Chou (14 shared papers)
- Journals
- International Journal of Molecular Sciences (16 papers)Cancers (5 papers)Oncotarget (5 papers)Cancer Research (5 papers)Biomaterials (4 papers)
- Partner nations
- TaiwanMalaysiaUnited States
In The Last Decade
Mong‐Lien Wang
96 papers receiving 4.1k citations
Mong‐Lien Wang's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 926
- Molecular Biology 2.3k
- Oncology 820
- Infectious Diseases 561
- Genetics 180
Countries citing papers authored by Mong‐Lien Wang
This map shows the geographic impact of Mong‐Lien Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mong‐Lien Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mong‐Lien Wang more than expected).
Fields of papers citing papers by Mong‐Lien Wang
This network shows the impact of papers produced by Mong‐Lien Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mong‐Lien Wang. The network helps show where Mong‐Lien Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mong‐Lien Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 499 | |
| 2 | A Review of SARS-CoV-2 and the Ongoing Clinical Trials Hit paper breakdown → | 2020 | 489 |
| 3 | 2011 | 195 | |
| 4 | 2013 | 143 | |
| 5 | 2020 | 137 | |
| 6 | 2018 | 135 | |
| 7 | 2021 | 118 | |
| 8 | 2012 | 118 | |
| 9 | 2015 | 116 | |
| 10 | 2013 | 115 | |
| 11 | 2021 | 105 | |
| 12 | 2013 | 82 | |
| 13 | 2019 | 75 | |
| 14 | 2011 | 70 | |
| 15 | 2003 | 66 | |
| 16 | 2018 | 62 | |
| 17 | 2003 | 62 | |
| 18 | 2020 | 57 | |
| 19 | 2002 | 56 | |
| 20 | 2019 | 56 |
About Mong‐Lien Wang
Mong‐Lien Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 97 papers that have together received 4.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (13 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Cancer Cells and Metastasis (10 papers), COVID-19 Clinical Research Studies (10 papers), Circular RNAs in diseases (10 papers), Retinal Development and Disorders (9 papers) and RNA modifications and cancer (9 papers). The work is most often cited by research in Cancer Research (926 citations), Molecular Biology (2.3k citations), Oncology (820 citations), Infectious Diseases (561 citations) and Genetics (180 citations). Mong‐Lien Wang has collaborated with scholars based in Taiwan, Malaysia and United States. Frequent co-authors include Shih‐Hwa Chiou, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, Shih-Hwa Chiou, Yueh Chien, Yi‐Ping Yang, Yung‐Hung Luo, Shih‐Jie Chou, Shih-Hwa Chiou and Pin‐I Huang. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Oncotarget, Cancer Research and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.